
Systematic review shows nurse-led predictive symptom monitoring using biomarkers and clinical judgment curbs oncology palliative emergencies
AI-summarized from the linked source. Educational brief, not medical advice.
Brief summary
A systematic review of 14 studies found that nurse-led predictive symptom management combining routine laboratory biomarkers with clinical nursing assessment enabled proactive intervention, decreased emergency department visits, and enhanced symptom control in cancer palliative care.
What NurseJet pulled from the source
Symptom distress in advanced cancer is traditionally addressed reactively after patients report severe breakthrough pain, delirium, or severe fatigue, frequently culminating in emergency department visits and crisis hospitalizations. This PRISMA systematic review (PROSPERO CRD420261432500) synthesized 14 clinical studies—including randomized controlled trials, cohort investigations, predictive modeling, and telehealth interventions—evaluating nurse-led predictive strategies in oncology palliative care. The synthesized evidence demonstrated that monitoring objective circulating biomarkers—notably C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), serum albumin, ferritin, and electrolyte derangements—predicted impending clinical deterioration and symptom crises. When bedside and ambulatory oncology nurses paired these biomarker trends with systematic clinical judgment, patients experienced superior symptom control, fewer acute emergency department visits, and more consistent care continuity.
Why this matters for nurses
Oncology and palliative care nurses frequently observe subtle shifts in patient functional status before acute decompensation occurs. Validating that nurses can pair objective inflammatory and nutritional biomarkers with clinical assessment transforms oncology nursing from reactive symptom relief into proactive crisis prevention, sparing fragile patients avoidable emergency room transfers.
Bedside takeaway
A systematic review of 14 studies found nurse-led predictive symptom management integrating biomarkers (CRP, NLR, albumin) with clinical judgment reduced ED visits and prevented acute decline in oncology palliative care.
Key takeaways
- Systematic review synthesized 14 clinical studies evaluating nurse-led predictive symptom management protocols in oncology palliative care.
- Laboratory biomarkers including CRP, neutrophil-lymphocyte ratio (NLR), albumin, ferritin, and electrolytes reliably heralded impending clinical decline.
- Nurse-coordinated integration of biomarker trends with structured clinical assessment shifted care from reactive firefighting to proactive symptom stabilization.
- Predictive nursing models were associated with reduced emergency department admissions and improved symptom-related quality of life.
Practice implications
- Review trending laboratory indicators (such as rising CRP, worsening NLR, or falling albumin) during oncology and palliative encounters as early alert signals for impending symptom crisis or disease progression, adjusting supportive care plans and symptom titration before severe functional decline develops.
Limitations & cautions
- Heterogeneity in study designs, biomarker panels, and tumor types across the 14 included studies; algorithms and predictive models require standardized electronic health record integration before universal bedside adoption.
- AI-summarized from the linked source. Review the original article before applying to practice.
Citations
Exact source links
Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.
Palliative & Supportive Care (PubMed)
Palliative & Supportive Care (PubMed). Nursing-led predictive symptom management in oncology palliative care: Using laboratory indicators and clinical judgment to improve patient quality of life: A systematic review.
https://pubmed.ncbi.nlm.nih.gov/42850936/
Professional education only


